Statistics
Publications
1.9K
Citations
46.2K
Authors
77
Location
Moscow, Russia
1.9K
77
P.A. Hertzen Moscow Oncology Research Institute, Russia
535 publications · 25.5K citations
50
h-index
P.A. Hertzen Moscow Oncology Research Institute, Russia
107 publications · 974 citations
20
h-index
P.A. Hertzen Moscow Oncology Research Institute, Russia
154 publications · 786 citations
16
h-index
P.A. Hertzen Moscow Oncology Research Institute, Russia
28 publications · 241 citations
10
h-index
P.A. Hertzen Moscow Oncology Research Institute, Russia
149 publications · 400 citations
10
h-index
1–5 of 77
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.4K citations · Full text
Medicine, Oncology, Pharmacology +9
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Robert J. Motzer, B. Yа. Alekseev, Sun Young Rha et al. · New England Journal of Medicine · 2021 · 1.8K citations · Full text
Medicine, Oncology, Pharmacotherapy +12
Andrew J. Armstrong, Russell Z. Szmulewitz, Daniel P. Petrylak et al. · Journal of Clinical Oncology · 2019 · 1.2K citations · Full text
Medicine, Oncology, Pharmacotherapy +17
Brian I. Rini, Thomas Powles, Michael B. Atkins et al. · The Lancet · 2019 · 1K citations
Medicine, Oncology, Pharmacology +13
Karim Fizazi, NamPhuong Tran, Luis Fein et al. · The Lancet Oncology · 2019 · 813 citations · Full text
Medicine, Oncology, Pharmacotherapy +16
1–5 of 1.9K